Cardiovascular Disease Doctors in Camden, NJ Accepting Medicare

21 Cardiovascular Disease doctors found. Showing 1 - 20

Niku Thomas, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2488

Omair Mohammad Javed, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 401 Haddon Ave, Room 369, Camden, NJ 08103 Phone: 856-757-7848

Dr. Manish S Dadhania, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 311, Camden, NJ 08103 Phone: 856-342-2683

Jan Richard Weber, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1600 Haddon Ave, Camden, NJ 08103 Phone: 856-365-4072    Fax: 856-580-6312

Alexander Smith, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 800-826-6737

Ri Do Cha, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 311, Camden, NJ 08103 Phone: 856-342-2034    Fax: 856-342-6608

Miss Maritza Cotto, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, 3 Dorrance, Camden, NJ 08103 Phone: 856-342-2604    Fax: 856-968-8282

Dr. Simon K. Topalian, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Cardiology Division, Camden, NJ 08103 Phone: 856-342-2000

Dr. Rajesh Mahesh Kabadi, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, 3rd Floor Dorrance, Camden, NJ 08103 Phone: 856-342-2000    Fax: 856-968-7420

Dr. Matthew L Ortman, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 311, Camden, NJ 08103 Phone: 856-342-2034    Fax: 856-342-6608

Kathleen M Heintz, DO Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 311, Camden, NJ 08103 Phone: 856-342-2034    Fax: 856-342-6608

Dr. Frank W. Bowen Iii, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plaza, Suite 502, Camden, NJ 08103 Phone: 856-342-3113    Fax: 856-541-5379

Mubashar H Khan, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Dorrance 3rd Floor, Camden, NJ 08103 Phone: 856-342-2624

Travante Mcnae Cartwright, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, Dorrance 261, Camden, NJ 08103 Phone: 856-342-2922

Zoltan G Turi, MD Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000

Dr. Brian Joseph Corbett, D.O. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Cooper Plz, 3 Dorrrance, Camden, NJ 08103 Phone: 856-342-2604    Fax: 856-968-8282

Lawrence J Gessman, MD Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 3 Cooper Plz, Suite 311, Camden, NJ 08103 Phone: 856-342-2034    Fax: 856-342-6608

Dr. Phillip A Koren, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz Rm 318, Camden, NJ 08103 Phone: 856-342-3491

Dr. Perry J. Weinstock, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3 Cooper Plz, Suite 311, Camden, NJ 08103 Phone: 856-342-2034    Fax: 856-342-6608

Dr. Devinder Singh, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Cooper Plz, Camden, NJ 08103 Phone: 856-342-2000

News Archive

Late-night tweeting by NBA players linked to worse personal statistics in games

Preliminary data from a new study suggests that NBA players had worse personal statistics in games that followed a late-night tweet between 11 p.m. and 7 a.m. Players scored on average about 1 point less in games following late-night tweets, and their shooting accuracy dropped 1.7 percentage points compared with their performance in games that did not follow late-night tweeting.

Dems to CMS: Hold firm on Medicaid 'MOE' requirements

Meanwhile, a Government Accountability Office report finds that, although most physicians still accept some new Medicaid or Children's Health Insurance Program patients, a majority of primary care docs say they have difficulty finding specialists to provide care for young low-income patients.

Japanese MHLW approves Hizentra for treatment of primary and secondary immunodeficiencies

CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.

Aeolus Pharmaceuticals raises $1.65 million from existing institutional shareholders

Aeolus Pharmaceuticals, Inc. announced today that it has completed a $1.65 million financing with several existing institutional shareholders, all of which are affiliates of Xmark Opportunity Partners, LLC. Under the terms of the financing, Aeolus received $1.65 million in gross proceeds in exchange for 5,892,857 Units (the "Units"), with each Unit comprised of one share of Aeolus Pharmaceuticals common stock, and a seven year warrant to purchase up to two additional shares of Aeolus Pharmaceuticals common stock at an initial exercise price of $0.28 per share, for a per Unit purchase price of $0.28.

Idera: IMO-3100 in lupus preclinical model suppressed several key disease progression parameters

Idera Pharmaceuticals, Inc. announced today that it is presenting data on IMO-3100, an antagonist of TLR7 and TLR9, in a preclinical model of lupus showing that treatment with IMO-3100 suppressed several key disease progression parameters.

Read more Medical News

› Verified 7 days ago

• 1(current)
• 2